Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MAC Pharmaceutical Investing
Kalytera Announces Formation of Strategic and Scientific Advisory Board to Assist with Development of Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain Biotech Investing
PreveCeutical Medical: Second Shipment of Dried Cannabis Materials Arrives at the Pharmacy Australia Centre of Excellence Biotech Investing
Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies Pharmaceutical Investing
